These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 10419733

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer.
    Rankins NC, Secord AA, Jewell E, Havrilesky LJ, Soper JT, Myers E.
    Gynecol Oncol; 2007 Aug; 106(2):388-93. PubMed ID: 17509672
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
    Cohn DE, Huh WK, Fowler JM, Straughn JM.
    Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE, Karnon J, Smith RE, Johnston SR, Brandman J, Sung JC, Gross PE.
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [Abstract] [Full Text] [Related]

  • 5. Cost effectiveness of a test to detect metastases for endometrial cancer.
    Havrilesky LJ, Maxwell GL, Chan JK, Myers ER.
    Gynecol Oncol; 2009 Mar; 112(3):526-30. PubMed ID: 19100608
    [Abstract] [Full Text] [Related]

  • 6. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [Abstract] [Full Text] [Related]

  • 7. Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective?
    Naeim A, Keeler EB.
    Breast Cancer Res Treat; 2005 Nov; 94(2):95-103. PubMed ID: 16261407
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.
    Zeliadt SB, Etzioni RD, Penson DF, Thompson IM, Ramsey SD.
    Am J Med; 2005 Aug; 118(8):850-7. PubMed ID: 16084177
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.
    Aballéa S, Chancellor JV, Raikou M, Drummond MF, Weinstein MC, Jourdan S, Bridgewater J.
    Cancer; 2007 Mar 15; 109(6):1082-9. PubMed ID: 17265519
    [Abstract] [Full Text] [Related]

  • 12. Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches.
    Barakat RR, Lev G, Hummer AJ, Sonoda Y, Chi DS, Alektiar KM, Abu-Rustum NR.
    Gynecol Oncol; 2007 Apr 15; 105(1):150-6. PubMed ID: 17197012
    [Abstract] [Full Text] [Related]

  • 13. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA, Havrilesky LJ, O'Malley DM, Bae-Jump V, Fleming ND, Broadwater G, Cohn DE, Gehrig PA.
    Gynecol Oncol; 2009 Sep 15; 114(3):442-7. PubMed ID: 19560193
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation.
    Fanning J, Hoffman ML, Andrews SJ, Harrah AW, Feldmeier JJ.
    Gynecol Oncol; 2004 Jun 15; 93(3):632-6. PubMed ID: 15196856
    [Abstract] [Full Text] [Related]

  • 15. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR.
    Anticancer Res; 2000 Jun 15; 20(3B):1977-84. PubMed ID: 10928137
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers.
    Porter GA, Cantor SB, Walsh GL, Rusch VW, Leung DH, DeJesus AY, Pollock RE, Brennan MF, Pisters PW.
    J Thorac Cardiovasc Surg; 2004 May 15; 127(5):1366-72. PubMed ID: 15115994
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis.
    Jewell EL, Kulasingam S, Myers ER, Alvarez Secord A, Havrilesky LJ.
    Gynecol Oncol; 2007 Dec 15; 107(3):532-40. PubMed ID: 17900674
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF, Haddad F, Siegel BA, Zoole JB, Battafarano RJ, Veeramachaneni N, Cooper JD, Patterson GA.
    J Thorac Cardiovasc Surg; 2006 Apr 15; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.